Literature DB >> 20970652

Considerations regarding major bleeding after cardiac transplantation.

A Diaz-Martin1, A M Escoresca-Ortega, C Hernandez-Caballero, M Pena, A Adsuar-Gómez, A Herruzo-Aviles, R Hinojosa-Perez.   

Abstract

Postoperative bleeding is one of the most frequent complications after cardiac surgery, leading to longer stays in the intensive care unit (ICU) and the hospital as well as increased morbidity and mortality. We designed an observational prospective study to evaluate early complications after cardiac transplantation, focusing on major bleeding and transfusion requirements. We also evaluated whether massive transfusion was related to increased morbidity and mortality. In patients who received ≥6 blood units, we observed significant differences regarding the need for continuous renal replacement techniques (50% vs 12.5%; P=.01) and ICU mortality (33.3% vs 4%; P=.01). This difference in mortality was also observed when comparing plasma transfusion requirements (35.3% vs 9.4%; P=.04). The overall mortality rate was 24.50%, showing significant differences in patients with massive transfusion (83.3% vs 37.8%; P=.008). In conclusion, perioperative bleeding and massive transfusion were associated with increased morbidity and mortality in this group of patients, which may prompt a review of surgical procedures and the introduction of new techniques, such as thromboelastography.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20970652     DOI: 10.1016/j.transproceed.2010.05.047

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  3 in total

1.  Fibrinogen concentrate as first-line therapy in aortic surgery reduces transfusion requirements in patients with platelet counts over or under 100×10(9)/L.

Authors:  Cristina Solomon; Niels Rahe-Meyer
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

2.  Risk factors for in-hospital mortality after coronary artery bypass grafting in patients 80 years old or older: a retrospective case-series study.

Authors:  Jacek Piątek; Anna Kędziora; Janusz Konstanty-Kalandyk; Grzegorz Kiełbasa; Marta Olszewska; Bryan HyoChan Song; Karol Wierzbicki; Irena Milaniak; Tomasz Darocha; Dorota Sobczyk; Bogusław Kapelak
Journal:  PeerJ       Date:  2016-12-01       Impact factor: 2.984

3.  Incidence and Risk Factors of Mortality in Nonagenarians and Centenarians After Intertrochanteric Fracture: 2-Year Follow-Up.

Authors:  Tao Wang; Junfei Guo; Yubin Long; Zhiyong Hou
Journal:  Clin Interv Aging       Date:  2022-04-05       Impact factor: 4.458

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.